Production tech tie-up boosts ProMetic's Chinese business
This article was originally published in Scrip
Executive Summary
The Canadian company ProMetic Life Sciences has taken another major step into the Chinese market through an order from a leading but undisclosed biopharma company in the country for technology to be used in the large-scale manufacture of a biosimilar product. ProMetic will supply its proprietary Mimetic Ligand affinity adsorbent, which is used to purify and eliminate pathogens from biologics during commercial manufacture.